Amanda J. McFarlane

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie, John B. G. Mackey, Thomas Jamieson et al. · Gut · 2022 · 228 citations · Full text

Medicine, Immunology, Oncology +17

Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans

S. Currie, Emily Gwyer Findlay, Amanda J. McFarlane et al. · The Journal of Immunology · 2016 · 139 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Amanda J. McFarlane, Henry J. McSorley, Donald J. Davidson et al. · Journal of Allergy and Clinical Immunology · 2017 · 127 citations · Full text

Life Sciences, Immunology, Microbiology +14

Respiratory syncytial virus infection influences tight junction integrity

Jeannette I. Kast, Amanda J. McFarlane, Anna Głobińska et al. · Clinical & Experimental Immunology · 2017 · 99 citations · Full text

Life Sciences, Cell Biology, Infectious Diseases +17

Combination peptide immunotherapy based on <scp>T</scp>‐cell epitope mapping reduces allergen‐specific <scp>I</scp>g<scp>E</scp> and eosinophilia in allergic airway inflammation

Karen J. Mackenzie, Paul M. Fitch, Melanie D. Leech et al. · Immunology · 2012 · 30 citations · Full text

Life Sciences, Immunology, Allergy +12